How Plague-Causing Bacteria Disarm Host Defense

 

May 24, 2007  |  

Effector proteins are the bad guys that help bacterial pathogens do their job of infecting the host by crippling the body’s immune system.  In essence, they knock down the front door of resistance and disarm the cell’s alarm system.

Now, researchers at the University of California, San Diego (UCSD) School of Medicine have identified a novel molecular target for an effector protein called YpkA, one of several effectors of the bacteria Yersinia – the pathogen responsible for the Middle Ages’ “Black Death” and a virulent form of food poisoning today.  Their study will be published online in the May 25 issue of Molecular Cell.

YpkA targets a host protein called Gaq, the messenger that transmits extracellular signals (“we are under attack!”) into the host cell, so that it can mount a defense.

“The alarm signal sent by Gaq is intercepted by YpkA, which sets up a roadblock along several cellular pathways that Gaq uses to deliver the alarm,” said lead author Lorena Navarro, Ph.D., post-doctoral researcher in the lab of the study’s principle investigator, Jack E. Dixon, Ph.D., professor of Pharmacology and Cellular and Molecular Medicine at the UCSD School of Medicine.  

Identifying this new target is the first step to developing effective strategies for preventing disease, including means to fight antibiotic-resistant strains of Yersinia that could be used in biological warfare, according to Navarro. 

The genus Yersinia includes three species of bacteria that are pathogenic to humans: Y. pestis is perhaps the most infamous, being responsible for the bubonic plague (also known as the Black Death), which killed more than 200 million people in the Middle Ages.

“This bacterial species could still be a threat today,” said Navarro, adding that scientists had isolated an antibiotic-resistant strain of this species.  In addition Y. pseudotuberculosis and Y. enterocolitica are big words for nasty, little bugs that cause what’s commonly known as food poisoning.  All three bacteria species find their way past the body’s immune system through a sophisticated invasion system that injects the effector proteins directly into the host cell’s cytoplasm.

“More than a decade after its discovery, our understanding of YpkA is still incomplete,” Navarro said.  “But Yersinia has maintained YpkA over millions of years, so it must be doing something important.”  The researchers speculate that YpkA plays an important role in disabling the body’s immune system beyond its previously known role of disrupting the host cell’s normal structure, which interferes with the cell’s innate ability to engulf and destroy invading bacteria.  “The question now becomes, why is Gaq targeted by YpkA?”

Additional investigators for the study include Antonius Koller and Susan Taylor, Ph.D., UCSD professor of chemistry and biochemistry; and Roland Nordfelth and Hans Wolf-Watz of Umeå University in Sweden.

Funding for the research was provided in part by the National Institutes of Health and a University of California President’s Postdoctoral Fellowship.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu

 

 




Media Contact

Share This Article


Related News

7/20/2017
The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved a $5.8 million award to University of California San Diego School o ...
7/10/2017
UC San Diego Health has been named one of the nation’s “Most Wired” health systems by Hospitals & Health Networks magazine, a publication of the American Hospital Association. The award recognizes hos ...
7/10/2017
Researchers at University of California San Diego School of Medicine have discovered differences in how the brain responds to food rewards in individuals with a history of bulimia nervosa (BN), an eat ...
7/5/2017
After 12 weeks of taking an anti-asthma drug, a subset of patients with type 2 diabetes showed a clinically significant reduction in blood glucose during a randomized, double blind, placebo-controlled ...



Follow Us